-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q3 2024.
- Maravai Lifesciences Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $36.8M, a 0.38% increase year-over-year.
- Maravai Lifesciences Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $149M, a 11% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2023 was $149M, a 12% decline from 2022.
- Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2022 was $169M, a 20.2% increase from 2021.
- Maravai Lifesciences Holdings, Inc. annual Cost of Revenue for 2021 was $141M, a 76.5% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)